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ABSTRACT
Objective: Genus Garcinia is well-known having rich xanthone compound contents and several of those are having biological activity as antimalarial. 
The aims of this research were to determine in vivo antiplasmodial activity of dichloromethane-ethyl acetate-methanol fractions of Mundu’s bark 
(Garcinia dulcis (Roxb.) Kurz), especially Fraction V against Plasmodium berghei and to determine effective dose 50 (ED50).
Methods: Making Fraction V from ethyl acetate extracts of Mundu’s bark with vacuum column chromatography method was applied using 
dichloromethane-ethyl acetate-methanol. The product was monitored by thin layer chromatography using silica gel GF-254 and a mobile phase of 
chloroform: Ethyl acetate (6:4). The same profiles from eluent composed Fraction 18 and 19 were categorized as Fraction V. Those were tested in each 
of groups animals with a dose of 12.5; 25; 50 and 100 mg/kg body weight. Antimalarial activity assessments have been performed with the in vivo 
P. berghei test. Plasmodial activity was obtained by calculating the percentage of parasitemia, parasitemia inhibition, and ED50 determination. ED50 
value determined based on the relationship between dose and the percentage of parasite growth inhibition by probit analysis.
Results: In this research, Antiplasmodial activity of Fraction V from Mundu’s bark displayed in a dose of 50 mg/kg bw and 100 mg/kg bw with 
inhibition parasite growth by values of 47.255% and 12.761%, respectively.
Conclusion: According to the research, Fraction V of Mundu’s bark (G. dulcis (Roxb.) Kurz) had the most potential antiplasmodial activity by in vivo 
test for male Swiss-Webster mice. The value of ED50 was reached by 47.424 mg/kg bw.
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INTRODUCTION
Malaria is still being a significant health problem around the world. 
World Health Organization predicted more than 40% residents in the 
world or about 2.3 billion people stayed in endemic areas of malaria. 
Malaria disease is also still found in all provinces of Indonesia. Based 
on annual parasite incidence’s stratification, Eastern Indonesia 
was in the high stratification of malaria, mid-stratification was in 
Kalimantan, Sulawesi, and Sumatera then Jawa-Bali were in the lowest 
stratification [1].
Malaria predicted has infected 300-500 M people in the world and 
caused death in 1.5-2.7 M sufferer in every year. This is caused by four 
of protozoa’s parasites; Plasmodium falciparum, Plasmodium vivax, 
Plasmodium ovale, and Plasmodium malariae that infect the human 
red blood cells. P. falciparum presented the resistant potency against 
mefloquine and haloforin, and perhaps, it had potential multiresistency 
to malaria’s drug in Africa [2,3]. Analog artemisinins such as artesunate 
and artemether were introduced indicating the effectively potency 
toward P. falciparum. However, the results of study of drug induction and 
relation between the dose and neurotoxicity in animal were feared about 
emerged safety from this compound in the human body [4]. Increasing 
of resistance to antimalarial drug, particularly synthesized drug such as 
chloroquine insisted on the effort to find new drug as an alternative of 
quinine and chloroquine that safe and has an affordable price.
Use of natural resources to resolve various diseases was carried out. 
Plants as potential resources of antimalarial have begun with finding 
quinine from bark of Chincona sp. continued with artemisinins from 
Artemisia annua. One of the genus Garcinia has known consist of many 
xanthone compounds and some of them have biological activity as 
antimalarial [1,5]. One of medicinal plants showing antiplasmodial 
activity has reported, there was Kandis’ bark [6]. Ethanolic extract of 
Garcinia dulcis Kurz also had antiplasmodial activity [7]. According to 
the study two kinds of xanthone compound from ethyl acetate fraction 
of Mundu’s bark, there were 1,3,4,5,8-pentahydroxyxanthone and 
1,4,5,8-tetrahydroxyxanthone [8].
Xanthone is plant contain that has phenolic nature, has also hydroxy 
group and is dissolved in semipolar solvent such as ethyl acetate [8]. 
Xanthone has biological activity and pharmacology as cytotoxic, 
antifungal, antimicrobial, antioxidant, antimalarial, anti-inflammatory, 
and also anti-HIV activities [5]. Fraction V contained dichloromethane-
ethyl acetate-methanol. By in vitro, Fraction V had the biggest potency 
compared with Fraction IV, VI and VII.
This study was aimed to test the antiplasmodial activity of Mundu’s bark-
Fraction V by in vivo in male Swiss-Webster mice that was induced with 
Plasmodium berghei with parameters of percentage of parasitemia test, 
retardation of parasitemia, and determination of effective dose 50 (ED50).
METHODS
Animals
Animals test used were 36 male and female Swiss-Webster mice with 
average weight of 20-30 g, 1.5-2.5 months old, induced with P. berghei. 
Permission and approval for animal studies were obtained from Faculty 
of Medicine, Gadjah Mada University, Yogyakarta.
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Preparation of P. berghei
P. berghei was found from infected broodstock mice (with P. berghei), 
taken from Medical Faculty of Universitas Gadjah Mada, Yogyakarta. 
Afterward, infected mice was taken their blood, looked for P. berghei 
concentration based on erithrocyte total by hemocytometer. Smear 
was made from mice’s blood with giemsa coloring to calculate 
infected eritrocyte to determine the concentration of Plasmodium. 
Concentration obtained was made up to 1×107 to be induced in other 
mice.
Plant material and fractionation
Mundu’s plant was obtained from Sukoharjo, Central Java. A part 
that was used was bark of the plant. Determination was performed 
at Biological Pharmacy Laboratory of Gadjah Mada University. The 
powder of Mundu’s bark was macerated with ethyl acetate for 5 days, 
extract was separated with vacuum column chromatography. Stationary 
phase used silica gel 60. From the separation was obtained 30 fractions. 
Fractions that had the same amount of chromatogram and Rf value was 
compiled so that was acquired 5 compiled fractions. Fraction V was a 
combination of 18 and 19.
In vivo test
Research layout used in this study was fully random same direction 
pattern using 36 Swiss-Webster mice that inoculated with P. berghei 
in the 1st day (D+0). In vivo antimalarial activity was performed 
based on Peter’s test (The 4 days suppressive test) [9]. Animals 
test were divided into 6 groups treatment that contained 6 mice in 
every group. There were Group I (-): Carboxymethylcellulose (CMC) 
suspension; Group II (+): Chloroquine suspension with 5 mg/kg bw/
day; Group III, IV, V: Fraction V suspension of Mundu’s bark with dose 
of 12.5 mg/kg bw; 25 mg/kg bw; 50 mg/kg bw; 100 mg/kg bw. CMC 
suspension, chloroquine, Fraction V of Mundu’s bark was given for 
4 days (D+0 until D3+) orally and the percentage of parasite growth 
was observed every day. Blood samples were taken to determine 
parasitemia level for 4 days. This result examined by making thin 
blood smear from mice’s tail with the Giemsa stain on the object 
glass.
Statistical analysis
Data taken from antiplasmodial activity test were calculated the 
percentage of parasitemia, percentage of parasitemia obstacle, and 
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While determination of ED50 based on the relationship between dose 
and the percentage of parasite growth inhibition by probit analysis.
RESULTS
Calculation of infected erythrocyte was shown in the Tables 1 and 2. To 
calculate the percentage of parasitemia used equation (1).
According to Tables 1 and 2, control (+) shown negative results. In 
general, negative control and suspension of Fraction V administration 
presented increasing percentage of parasitemia both in male and female 
mice. In male mice, the average percentage of parasitemia was between 
0.192% and 9.148%, while in female mice was just 8.403%. The bigger 
dose exposured in animals test, the less parasitemia value decreased 
in average, except for dose 100 mg/kg bw. It meant the higher of the 
average percentage of parasitemia, the more infectious P. berghei in 
Swiss-Webster mice conversely.
Inhibition percentage of parasitemia
Determination of ED50 value based on percentage of inhibition parasite 
growing was observed in the end of administration (D+4) using 
equation (2).
According to Tables 3 and 4, those can be seen the average of 
parasitemia obstacle by either male or female mice. Tukey’s honestly 
significant difference analysis indicated that a dose of 50 mg/kg bw 
gave the differentiation with the negative control for inhibition parasite 
growth. In general, the less average percentage of parasitemia, the 
bigger average percentage of parasitemia obstacle. ED50 defined the 
ED50 required to inhibit a half of P. berghei that was infected in mice. 
Based on antiplasmodial activity test, the relationship between dose 
and the percentage of parasite growth inhibition by probit analysis the 
value of ED50 in male mice by Fraction V of Mundu’s bark was obtained 
47.424 mg/kg bw and in the female was obtained 8053,784 mg/kg bw.
DISCUSSION
In vivo-antiplasmodial activity test in this research was performed 
based on Peter’s test (The 4 days supresive test). Inoculation of 
P. berghei in male Swiss-Webster mice had several advantages where 
male Swiss mice were quite sensitive toward the parasite infection 
and had more resistance against the infection that other mice. In the 
latest research conducted by Widodo and Rahayu [10], the highest 
antimalarial activity in the same condition as this research was achieved 
by a dose of 50 mg/kg bw of ethyl acetate fraction from Mundu’s bark. 
The extract of Mundu’s bark with n-hexane presented antiplasmodial 
activity through decreasing of parasitemia, particularly with a dose 
of 100 mg/kg bw could decrease parasitemia effectively [11]. In this 
research, antiplasmodial activity of Fraction V from Mundu’s bark 
displayed in a dose of 50 mg/kg and 100 mg/kg bw with values of 
47.255% and 12.761%, respectively.
Fraction V showing antiplasmodial activity from 4 various doses were 
50 mg/kg bw and 100 mg/kg bw. This was caused by active compound 
showing antiplasmodial activity. There was xanthone that the most 
concentration was found in both doses. Besides, from the various dose 
Table 1: Average percentage of parasitaemia in male 
Swiss‑Webster mice
Test group  
(mg/kg bw)
Average percentage±SD (%)
D+1 D+2 D+3 D+4
Control (-) 0.192 1.758±0.933 6.865±3.229 9.148±5.922
Control (+) - - - -
12.5 - 0.645±0.161 4.357±1.903 10.058±4.015
25 - 0.907±0.455 4.283±2.987 9.151±5.597
50 - 0.416±0.388 1.626±1.565 4.825±4.195
100 - 0.678±0.522 2.782±1.646 7.981±3.870
SD: Standard deviation
Table 2: Average percentage of parasitemia in female 
Swiss‑Webster mice
Test group  
(mg/kg bw)
Average percentage±SD (%)
D+1 D+2 D+3 D+4
Control (-) 0 1.867±1.016 4.750±3.916 8.403±6.606
Control (+) 0 0,000 0,000 0.000
12.5 0 1.587±0.798 4.760±3.642 7.766±6.900
25 0 0.806±0.599 3.822±3.116 8.589±5.252
50 0 0.420±0.328 1.742±1.714 4.830±4.067
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exposured, these doses were the biggest. However, the antiplasmodial 
activity shown different values between dose of 50 mg/kg bw and 
100 mg/kg bw.
ED50 that can inhibit a half of parasite growing (ED50) was counted based 
on the relationship between dose and percentage of inhibition parasite 
growing by compound test with prohibit analysis. Antiplasmodial 
activity of plant extract was divided into 3 types; the most potent 
extract (ED50<100 mg/kg bw), potential extract (100 mg/kg bw <ED50 
<100 mg/kg bw) and less potential (ED50>500 mg/kg bw) [12]. From 
this research, ED50 was achieved by 47.424 mg/kg bw so that it has 
the most potential of antiplasmodial activity. In this research, it was 
yet conducted working mechanism of Fraction V. Fraction V contained 
xanthone, tannin, and flavonoid. Xanthone was the compound 
that respect to this antiplasmodial activity [1,6,7]. Even though 
antiplasmodial activity of xanthone has not clearly defined yet, but it is 
estimated forming dissolve complex compound with heme-protein to 
block hemozoin parasite forming [13]. Forming hemozoin is the process 
where parasite protects itself from toxic effect of releasing heme after 
the digestion of hemoglobin. This action model from xanthone probably 
interacts with monomer of heme, between Fe3+-heme and oxygen from 
carbonyl group and interaction between both of aromatic system, and 
side group function of carboxylic between heme and xanthone in the 
fourth and fifth position [14].
CONCLUSION
According to the research, Fraction V of dichloromethane-ethyl acetate-
methanol of Mundu’s bark (G. dulcis (Roxb.) Kurz) had the most 
potential antiplasmodial activity by in vivo test for male Swiss-Webster 
mice, with an ED50 value was 47.424 mg/kg bw.
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Table 3: Inhibition percentage of parasitemia at the fourth day in male mice
Dose (mg/kg bw) % Inhibition parasitemia
Mice 1 Mice 2 Mice 3 Mice 4 Mice 5 Mice 6 Average±SD
12.5 −34.696 −21.349 - - −38.697 54.941 −9.950±43.892
25 - 97.967 15.184 −50.055 −49.497 −13.763 −0.033±61.182
50 8.013 73.798 81.941 56.777 −25.426 88.424 47.255±45.860
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Control (+) 100 100 100 100 100 100 100±0
SD: Standard deviation
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100 −21.433 −5.784 67.107 −38.855 - 49.875 10.182±46.030
Control (+) 100 100 100 100 100 100 100±82.113
SD: Standard deviation
